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Th e fi rst seizure is an event that may have pro-
found emotional, social, and vocational consequences 
in child’s life. Prospective, population-based stud-
ies indicate that we all face an 8-10% lifetime risk of 
one seizure and 3% chance of epilepsy. A fi rst seizure 
caused by an acute disturbance of brain function (acute 
symptomatic or provoked) is unlikely to recur (3-10%). 
If a fi rst seizure is unprovoked seizure, however, meta-
analyses suggest that 30-50% will recur. After a sec-
ond unprovoked seizure, 70-80% will recur, justifying 
the diagnosis of epilepsy.
When evaluating a child who has experienced a 
fi rst seizure, the clinician needs to address an identi-
fi able etiology, the most appropriate therapy and the 
prognosis. Many 
disorders can mimic seizures in children and 
should be considered in the diff erential diagnosis of 
fi rst seizure in child. Th e prognosis of seizures in chil-
dren and the risk of recurrence depend mainly of their 
underlying epileptic syndrome. Th e most important 
predictors of recurrence include partial seizures, mo-
tor defi cit , mental retardation, abnormal imaging and 
abnormal EEG. Cryptogenic seizurs while awake and 
associated with a normal EEG have a favorable prog-
nosis and risk of recurrence of 21% in 5 years, whereas 
symptomatic seizures may have up to a 96% chance of 
recurrence.
Drug treatment after a fi rst seizure is controver-
sial. Treatment with antiepileptic medications reduces 
the risk of early seizure recurrence, but has not been 
shown to aff ect the long-term prognosis for develop-
ing epilepsy in children ( and in adults). AED therapy 
is not always benign and can be associated with rare 
and fatal allergic reactions and more common adverse 
eff ects that are not medically dangerous but do lower 
the quality of life. 
 Th us, treatment with AEDs should not be auto-
matic after a fi rst seizure. Th e decision of wheter to 
treat should be made on an individual case basis that 
balances the risk of reccurent seizure and disability 
against the likely impact of medication-related physi-
cal and psychological adverse eff ects.
